News
Latest News, Announcements, and Press Releases
28Jul 14
Gordon Sangster to Join Codexis as Senior Vice President & Chief Financial Officer
REDWOOD CITY, Calif., July 28, 2014 (GLOBE NEWSWIRE) — Codexis, Inc. (Nasdaq:CDXS), a leading developer of biocatalysts for the pharmaceutical and fine chemical industries, today announced that Gordon Sangster has agreed to join Codexis as Senior Vice President…
read more14Jul 14
Codexis Announces Technology Collaboration and License Agreement With GSK
Codexis to Receive Up to $25 Million of Initial Payments, Plus Additional Milestone and Royalty Opportunities Codexis to Host a Conference Call on July 15, 2014 at 8:30 a.m. ET / 5:30 a.m. PT REDWOOD CITY, Calif., July…
read more07May 14
Codexis Reports Financial Results for the First Quarter of 2014
Conference Call today at 4:30 pm ET REDWOOD CITY, Calif., May 7, 2014 (GLOBE NEWSWIRE) — Codexis, Inc. (Nasdaq:CDXS), a leading developer of biocatalysts for the pharmaceutical and fine chemical industries, today announced its financial results for the…
read more30Apr 14
Codexis to Announce First Quarter 2014 Financial Results on May 7, 2014
REDWOOD CITY, Calif., April 30, 2014 (GLOBE NEWSWIRE) — Codexis, Inc. (Nasdaq:CDXS), a leading developer of biocatalysts for the pharmaceutical and fine chemical industries, today announced it will host a live conference call and audio webcast on Wednesday,…
read more13Mar 14
Codexis Sells Its Hungarian Operations to Intrexon Corporation
REDWOOD CITY, Calif., March 13, 2014 (GLOBE NEWSWIRE) — Codexis, Inc. (Nasdaq:CDXS), a leading developer of biocatalysts for the pharmaceutical and fine chemical industries, today announced the sale of its subsidiary in Hungary to Intrexon Corporation. The transaction…
read more11Mar 14
Codexis Reports Fourth Quarter and Full Year 2013 Results
Conference Call Today at 4:30 pm ET REDWOOD CITY, Calif., March 11, 2014 (GLOBE NEWSWIRE) — Codexis, Inc. (Nasdaq:CDXS), a leading developer of biocatalysts for the pharmaceutical and fine chemical industries, today announced its financial results for the…
read more27Feb 14
Codexis Appoints Biopharmaceuticals Industry Veteran, Patrick Yang, Ph.D., to Board of Directors
REDWOOD CITY, Calif., Feb. 27, 2014 (GLOBE NEWSWIRE) — Codexis, Inc. (Nasdaq:CDXS), a leading developer of biocatalysts for the pharmaceutical and fine chemical industries, today announced the appointment of Patrick Yang, Ph.D., to its board of directors. Dr.…
read more25Feb 14
Codexis to Announce Fourth Quarter and Fiscal Year 2013 Financial Results on March 11, 2014
REDWOOD CITY, Calif., Feb. 25, 2014 (GLOBE NEWSWIRE) — Codexis, Inc. (Nasdaq:CDXS), a leading developer of biocatalysts for the pharmaceutical and fine chemical industries, today announced it will host a live conference call and audio webcast on Tuesday,…
read more04Feb 14
Codexis to Present at 16th Annual BIO CEO & Investor Conference
REDWOOD CITY, Calif., Feb. 4, 2014 (GLOBE NEWSWIRE) — Codexis, Inc. (Nasdaq:CDXS), a leading developer of biocatalysts for the pharmaceutical and complex chemistry industries, today announced that John Nicols, President and CEO of Codexis, will present a company…
read more28Jan 14
Professor Chi-Huey Wong wins 2014 Wolf Prize in Chemistry for work in Biocatalysis
Congratulations to Professor Chi-Huey Wong on winning the 2014 Wolf Prize in Chemistry for his pioneering work in Biocatalysis. Professor Wong has been recognized by the foundation for the development of chemo-enzymatic syntheses “that enable the previously impossible or infeasible…
read moreSince 2002, Codexis has created new technologies to unlock the power of proteins®. Put our unmatched protein engineering expertise to work for you.
Unlock the power of proteins® with Codexis
Learn More
Company
Industries